ARRY-403

CAS No. 1138669-65-4

ARRY-403( —— )

Catalog No. M34507 CAS No. 1138669-65-4

ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1502 Get Quote
5MG 1881 Get Quote
10MG 2537 Get Quote
25MG 3643 Get Quote
50MG 4904 Get Quote
100MG 6471 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ARRY-403
  • Note
    Research use only, not for human use.
  • Brief Description
    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
  • Description
    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1138669-65-4
  • Formula Weight
    454.52
  • Molecular Formula
    C20H18N6O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1ncccc1Oc1cc(Sc2ccccn2)cnc1Nc1nc(ns1)[C@H](O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (1S,2R)-Globalagliat...

    (1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.

  • Butyl isobutyl phtha...

    Butyl isobutyl phthalate is a non-competitive α-glucosidase inhibitor(IC50 :38 μM)it shows a hypoglycemic effect.

  • AZ PFKFB3 26

    AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM.